secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-06-16T12:30:22+00:00
Accession:  0001493152-26-028823
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies to host veteran lung cancer webinar July 21, 2026
--------------------------------------------------------------------------

- Webinar features Philips, 4DMedical, and NAVREF discussing lung health screening for veterans.
- CyPath Lung test cited: 92% sensitivity, 87% specificity, 99% NPV in published trial.
- Event is educational; no financial guidance or operational updates provided.
- No changes to company outlook or product commercialization disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226028823/0001493152-26-028823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226028823/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer